Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001595215-17-000001
Filing Date
2017-07-21
Accepted
2017-07-21 15:48:53
Documents
1
Effectiveness Date
2017-07-21
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 7069
  Complete submission text file 0001595215-17-000001.txt   8113
Mailing Address 10581 ROSELLE STREET, SUITE 115 SAN DIEGO CA 92121
Business Address 10581 ROSELLE STREET, SUITE 115 SAN DIEGO CA 92121 858-925-5619
Aspyrian Therapeutics, Inc. (Filer) CIK: 0001595215 (see all company filings)

EIN.: 272624716 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-291296 | Film No.: 17976561